The company paused testing of one candidate acquired in its April deal for Escient and scrapped another in a blow to its ...

Today, a brief rundown of news involving Astellas and Cytokinetics, as well as updates from Cybin, Neurogene and Novartis ...

An experimental pill developed by Johnson & Johnson and Protagonist Therapeutics significantly cleared skin in most people ...

ZetaMet™ (Zeta-BC-003) is a synthetic, small-molecule, delivered via a proprietary controlled- release carrier intended to resolve metastatic breast cancer bone lesions, inhibit pain while ...